Skip to main content

Management of vascular graft stenosis in a patient with recurrent thrombosis

Case Takeaways

  • In this case, balloon angioplasty management of the previous left arm graft ultimately resulted in graft failure and recurrent thrombosis at just under two years
  • At six years the right arm graft has maintained significantly longer secondary patency than the original left arm graft, with no further episodes of graft thrombosis after placement of the GORE® VIABAHN® Endoprosthesis at the venous anastomosis
  • The GORE® VIABAHN® Endoprosthesis is an excellent option for management of the venous anastomosis of AV grafts versus balloon angioplasty, as demonstrated in the Gore REVISE Clinical Study1

In the Gore REVISE Clinical Study, the GORE® VIABAHN® Endprosthesis lowered the mean number of interventions over two years by 40% in thrombosed grafts2

EDWARDS and FOGARTY® are trademarks of Edwards Lifesciences Corporation.

The outcomes and observations reported are based on individual case experience and the patients treated. The steps described here may not be complete, and are not intended to be a replacement for the Instructions for Use or the education, training and professional judgment of Healthcare Providers. Healthcare Providers remain solely responsible for making decisions about patient care and the use of medical technologies.

Visit our clinical uses page

1. Vesely T, DaVanzo W, Behrend T, Dwyer A, Aruny J. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. Journal of Vascular Surgery 2016; 64(5):1400-1410.e1. http://www.sciencedirect.com/science/article/pii/S0741521416301756

2. Mohr BA, Sheen AL, Roy-Chaudhury P, Schultz SR, Aruny JE; REVISE Investigators. Clinical and economic benefits of stent grafts in dysfunctional and thrombosed hemodialysis access graft circuits in the REVISE Randomized Trial. Journal of Vascular & Interventional Radiology 2018;30(2):203-211.e4.